Dechra Pharmaceuticals Reports Rise In Profit

Dechra Pharmaceuticals PLC (PINK: DPHAF) reported a 15% rise in its adjusted pretax profit for the year ended June 30, 2011.

Dechra Pharmaceuticals' adjusted pretax profit for the year came in at GBP30.1 million. Its revenue came in at GBP389.2 million. Dechra Pharmaceuticals reported its operating profit at GBP21.7 million. Dechra Pharmaceuticals adjusted earnings per share came in at 34.22 pence.